Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
Hikma Pharmaceuticals USA Inc.

FDA Inspection

•Hikma Pharmaceuticals USA Inc.•November 3, 2023

FDA Inspection 1222115 - Hikma Pharmaceuticals USA Inc. - November 03, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Hikma Pharmaceuticals USA Inc., with an inspection on November 3, 2023, covering drugs.

Company: Hikma Pharmaceuticals USA Inc.
Inspection Date: November 3, 2023
Product Type: Drugs

Open in Dashboard

ID · e7b030d5-aa1b-472b-8874-97ba0cb35d84

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1222115 - Hikma Pharmaceuticals USA Inc. - November 03, 2023 | Global Key Solutions